Navigation Links
Par Pharmaceutical To Acquire Anchen Pharmaceuticals
Date:8/24/2011

sk factors that might affect such forward-looking statements include those set forth in Item 1A of the Company's most recent Annual Report on Form 10-K, in other of the Company's filings with the SEC from time to time, including Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and on general industry and economic conditions.  Any forward-looking statements included in this news release are made as of the date hereof only, based on information available to the Company as of the date hereof, and, subject to any applicable law to the contrary, the Company assumes no obligation to update any forward-looking statements.


'/>"/>
SOURCE Par Pharmaceutical Companies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference
2. Valeant Pharmaceuticals Files a Notice of Intention to Make a Normal Course Issuer Bid
3. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
4. Mainor Eglet Attorney, Robert Eglet, Calls Teva Pharmaceuticals Vice President Craig Lea to the Stand in Hepatitis C Trial
5. Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
6. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
7. Valeant Pharmaceuticals Completes Acquisition of Sanitas Group
8. CoLucid Pharmaceuticals Receives Clearance for Investigational New Drug (IND) Application for Lasmiditan for the Treatment of Acute Migraine
9. Valeant Pharmaceuticals Announces Resignation of Michael Van Every From Valeants Board of Directors
10. Endo Pharmaceuticals Announces Termination of Collaboration with Grunenthal for the Development of Axomadol
11. Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Cardinal Innovations Healthcare Solutions , ... high-touch service delivery, is featuring its highly successful ... National Council for Behavioral Health,s annual National Conference ... 2015, at the Gaylord Palms Resort and Convention ... attracts participants from mental health and addiction treatment ...
(Date:4/20/2015)... 20, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today shared highlights of new ... Cancer Research (AACR) annual meeting. Halozyme also announced ... Phase 2 study in pancreatic cancer, Study 202, ... American Society of Clinical Oncology (ASCO). ...
(Date:4/20/2015)... , April 20, 2015  Published results ... trends in the ability of Neuraltus Pharmaceuticals ... of amyotrophic lateral sclerosis (ALS, also known as ... treatment period. While NP001,s slowing of decline in ... was not statistically significant, clinically meaningful slowing of ...
Breaking Medicine Technology:Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 2Cardinal Innovations Highlights its Managed Care Model During National Council for Behavioral Health's Annual Conference 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5
... Pursuant to the filing of a Form 13D with the ... global leader in protection solutions, today announced it has made ... acquired 9.66% of the issued and outstanding shares of common ... manufactures and sells a comprehensive line of safety garments and ...
... SCOLR Pharma, Inc. (OTCQB: SCLR) today announced that ... its extended-release nutritional products based on the Company,s proprietary ... first significant direct retail sales of its nutritional products. ... CEO, said, "Shipment of these initial orders marks an ...
Cached Medicine Technology:SCOLR Pharma, Inc. Announces Initial Shipments of its Nutritional Products 2
(Date:4/20/2015)... Mutare Health, a Strategic Business ... Lawrence Kosinski, MD, MBA, AGAF, to serve as ... a unique combination of medical experience, technical expertise, ... Health team as it continues to develop ... of care in the healthcare environment. He is ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Goodreads is ... Health Insurance: Why It’s Good for You and Your ... Paul Zane Pilzer and Rick Lindquist have released ... Insurance: Why It’s Good for You and Your Company. ... employer health insurance woes - employer-funded individual health insurance. ...
(Date:4/20/2015)... April 20, 2015 Advance Home Care ... personal matter that many customers would prefer not to share ... March 30th a discreet delivery method allowing customers to order ... at their home without fear of a neighbor or passerby ... method is available now on all orders and no minimum ...
(Date:4/20/2015)... Florida Hospital at Connerton Long Term ... from Select Medical, during the annual ceremony hosted at ... Chief Operating Officer, Debi Martoccio, received the Leadership Award ... of six recipients out of 113 hospitals nationwide. The ... for the contributions to the community as well as ...
(Date:4/20/2015)... 1% for the Planet , one of the ... Williams, the network’s Director of Partnerships, will step into the ... been part of 1% for the Planet since early 2014, ... Northern Forest Canoe Trail, a 1% for the Planet nonprofit ... of and advocacy for the outdoors, a commitment which is ...
Breaking Medicine News(10 mins):Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 2Health News:Advance Home Care Supply Proud to Offer Discreet Delivery For All Orders 3Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 2Health News:Florida Hospital at Connerton Long Term Acute Care Earns Awards from Select Medical including the Stu Dinney Humanitarian Award 3Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3
... , WEDNESDAY, Jan. 5 (HealthDay News) -- Women with ... to have a gene thought to be connected to the ... help researchers gain more insight into the development of MS, ... particularly among women. Although no one knows what causes MS, ...
... Lou Gehrig,s disease, or amyotrophic lateral sclerosis (ALS), ... clumps in brain and spinal-cord cells that include an ... building block of the lesions formed by these clumps. ... Journal of Clinical Investigation , a team led by ...
... are reporting development of a less expensive, more eco-friendly method ... may be a more healthful form of water. Their report ... Research . Changgong Meng and Feng Huang note ... mixture of H2O and tiny amounts of D2O about ...
... of researchers at the Columbia University College of Dental ... key role in vascular pathogenesis, specifically atherosclerosis, or what ... the number one cause of death in the ... in cardiovascular diseases has been challenging because researchers have ...
... maximum temperature of children,s bath water can significantly reduce ... the risk of scalding, according to researchers at The ... partnership with Glasgow Housing Association, found that families with ... and cold water pipes in their bathroom had bath ...
... New Rochelle, NY, January 5, 2011A new, simplified method ... of shuttling genes into host cells will help advance ... into large animal studies and human clinical trials. The ... an article published Instant Online ahead of publication in ...
Cached Medicine News:Health News:Study Sheds Light on Genetic Risk of MS 2Health News:Malfunctioning gene associated with Lou Gehrig's disease leads to nerve-cell death in mice 2Health News:Bacteria eyed for possible role in atherosclerosis 2Health News:Bacteria eyed for possible role in atherosclerosis 3Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 2Health News:Thermostatic mixer valves could significantly reduce the risk of scalding in children, study finds 3Health News:Faster, scalable method for producing AAV-based gene transfer vectors 2
Bio-Rad's Liquichek™ D-dimer Control provides the laboratory with a liquid, trilevel, human plasma based control for the monitoring of D-dimer testing on most automated coagulation, chemistry a...
Lyphochek Coagulation Control is a human plasma control for monitoring the performance of routine coagulation tests. It has an extended reconstituted stability which helps reduce waste and save money...
Lyphochek Diabetes Control is a human whole blood based product used to monitor hemoglobin fractions associated with diabetes, including Hemoglobins A1, A1C, F and Total Glycated Hemoglobin....
... Liquichek Qualitative Urine Toxicology Control is a ... rapid urine drug screen panels, including Point ... test kits like Bio-Rad TOX/See, Biosite Triage ... qualitative results (+/) for popular kits and ...
Medicine Products: